2021
DOI: 10.1016/j.bbi.2021.03.024
|View full text |Cite
|
Sign up to set email alerts
|

Polygenic risk for immuno-metabolic markers and specific depressive symptoms: A multi-sample network analysis study

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
23
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 39 publications
(27 citation statements)
references
References 88 publications
4
23
0
Order By: Relevance
“…41 In keeping with these findings, polygenic scores influencing higher CRP levels were positively associated with increasing altered appetite and fatigue (along with TNF-α), suggesting that genetic predisposition to higher systemic inflammatory markers are primarily associated with somatic/neurovegetative symptoms of depression. 42 This evidence was supported by a multi-sample network analysis in depressed and general population cohorts, and is also consistent with previous observational studies on circulating inflammation markers in population cohorts. 7,43 Moreover, Mendelian randomization analyses suggested a causal effect of increased CRP on somatic symptoms (appetite alterations, tiredness/…”
Section: Discussionsupporting
confidence: 90%
“…41 In keeping with these findings, polygenic scores influencing higher CRP levels were positively associated with increasing altered appetite and fatigue (along with TNF-α), suggesting that genetic predisposition to higher systemic inflammatory markers are primarily associated with somatic/neurovegetative symptoms of depression. 42 This evidence was supported by a multi-sample network analysis in depressed and general population cohorts, and is also consistent with previous observational studies on circulating inflammation markers in population cohorts. 7,43 Moreover, Mendelian randomization analyses suggested a causal effect of increased CRP on somatic symptoms (appetite alterations, tiredness/…”
Section: Discussionsupporting
confidence: 90%
“…Significant enrichment of genes involved in protein degradation pathways as well as the predictive capacity of risk for cardioembolic stroke, however, support a link between LLD and risk for vascular dysfunction [ 198 ]. Other large GWAS data showed co-heritability between CRP levels and individual depressive symptoms [ 199 ] and that inflammatory markers are associated with neurovegetative symptoms of depression [ 200 ]. A GWAS of cognitive functional decline in individuals with LLD identified candidate genes, including SLC27A1, involved with processing docosahexaenoic acid (DHA), an endogenous neuroprotective component in the brain that is reduced in these patients [ 201 ].…”
Section: Challenging Pathomechanismsmentioning
confidence: 99%
“…Since VaD is often associated with increased inflammation biomarkers [ 105 ], neuroinflammation may be a key therapeutic target for therapeutic strategies in LLD [ 66 , 200 ], and a meta-analysis suggested that nonsteroidal anti-inflammatory agents (NSAID) and cytokine antagonists have antidepressant properties in relevant patients [ 229 ]. Efficacious psychotherapies for LLD may include streamlined, neurobiologically based methods targeting behavioral domains assumed to result from dysfunctions of specific brain networks [ 33 ], or neuroplasticity-based computerized cognitive remediation programs [ 230 ], but their effectiveness needs to be validated.…”
Section: Implications For Clinical Practice and Managementmentioning
confidence: 99%
“… 42 These results differ from the findings of the current study. Similarly, the application of the network model has considered the assessment of polygenic risk measures of BMI, as observed in the study by Kappelmann et al, 43 who evaluated 3 national samples and found that, in 2 of them, the polygenic risk measure of BMI presented a greater association with the items “Low interest and dissatisfaction” (PH1) and “Problems with sleep” (PH3). This finding is consistent with our results that evidenced higher scores of depressive symptoms in the obesity group.…”
Section: Discussionmentioning
confidence: 99%